Article Details

Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical ...

Retrieved on: 2018-10-15 17:00:00

Tags for this article:

Click the tags to see associated articles and topics

Applied DNA Subsidiary LineaRx Licenses CAR T Drug Candidate and Initiates Pre-Clinical .... View article details on hiswai:

Excerpt

<div>STONY BROOK, N.Y.--(BUSINESS WIRE)--<b>Applied DNA Sciences</b> Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), the leader in large-scale ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up